Ventriküler Destek Sistemleri

Gallois CJJ. Experiences on the principle of life. Philadelphia: Charles C Thomas, 1813. Translation of LeGallois CJJ. Experience sur la principe de la vie. Paris, 1812.

Gibbon JH. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med, 1954; 37:171.

Spencer FC, Eiseman B, Trinkle JK, Rood NP. Assited circulation for cardiac failure following intracardiac surgery with cardiorespiratory bypass. J Thorac Cardiovasc Surg, 1959;49:56.

Stuckey JH, Newman MM, Dennis C et al. The use of the heart-lung machine in selected cases of acute myocardial infarction. Surg From, 1957;8:342-4.

Dennis C, Carlens E, Senning A et al. Clinical use of a cannula for left heart bypass without thoracotomy. Ann Surg, 1962;156:623.

Liotta D, Taliani T, Giffoniello AH et al. Artificial heart in the chest: Preliminary report. Trans Ann Soc Artif Intern Organs, 1961;7:318-22.

Liotta D, Crawford ES, Cooley DA et al. Prolonged partial left ventricular bypass by means of an intrathoracic pump implanted in the chest. Trans Ann Soc Artif Organs, 1962;8:90-9.

DeBakey ME. Left ventricular bypass pump for cardiac assistance. Clinical experience. Am J Cardiol, 1971;27:3-11.

Liotta D: Early clinical application of assisted circulation. Tex Heart Inst J, 2002;29:229-30.

Moulopoulos SD, Topaz S, Kolff WJ. Diastolic balloon pumping (with carbondioxide) in the aorta. Mechanical assistance of the failing circulation. Am Heart J, 1962;63:229.

Kantrowitz A, Tjonneland S, Freed PS et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA, 1968;203:135.

Reemstma K, Drusin R, Edie R, et al. Cardiac transplantation for patients requiring mechanical circulatory support. J Engl J Med, 1978;298:670.

Norman JC, Brook MI, Cooley DA et al. Total support of the circulation of a patient with postcardiotomy, artificial heart (AL-VAD) for 5 days followed by heart and kidney transplantation. Lancet, 1978;1:1125.

Portner PM, Oyer PE, McGregor CG et al. First human use of an electrically powered implantable ventricular assist system. Artif Organs, 1985;9:36.

Frazier O, Duncan J, Radovancevic B et al. Successful bridge to heart transplantation with a new left ventricular asist device. J Heart Lung Transplant 1992;11:530.

Dew M, Kormos D, Roth L, Life Quality in the area of bridging to cardiac transplantation: Bridge patients in an outpatient setting. ASAIO J, 1993;39:145.

Frazier O. First use of an untethered, vented electric left ventricular asist device for long term support. Circulation 1994;89:2908.

FDA News for immediate release, 2002;P02-48.

McCarthy PM, Smedira NO, Vargo RL et al. One hundred patients with the HeartMate left vantricular assist device: Evolving concepts and technology. J Thorac Cardiovasc Surg, 1998;115:904-12.

Güner S, Yaşa B, Kantaroğlu B, Küçükaksu DS et al. Postkardiyotomi kardiyojenik şok tedavisinde ventriküler destek aygıtlarının kullanımı. XIV.Ulusal Kardiyoloji Kongresi Abstr, 1998;92.

Taşdemir O, Şener E, Küçükaksu DS ve ark. Kalp transplantasyonuna bridging amaçlı DeBakey VAD implantasyonu: Türkiye’deki ilk deneyim. XVII Ulusal Kardiyoloji Kongresi (özet kitabı), 2001;29:145.

Küçükaksu DS, Şener E, Undar A, Tasdemir O. First Turkish experience of implantable left ventricular assist device for bridging to transplantation. I. Cleveland Clinic Foundation Heart Failure& Circulatory support Summit, Cleveland, 2002;12.

Ozbaran M, Yagdi T, Engin C et al. Mec-hanical cardiac support in the adult with the Berlin Heart EXCOR pulsatile ventricular assist device: Report of the first two case. Artificial Organs, 2007;31:10.

Kucukaksu DS, Wieselthaler G, Goksedef D et al. The first implantation of DeBakey VAD for destination therapy in Turkey. Artificial Organs, 2007;10:116.

Eygi B, Ertugay S, Turhan S et al. Intracorporeal LVAD applications: Ege University experience. 2. TUYOD (Yapay Organlar ve Destek Sistemleri) Kongresi 2009;4:S06.

High-Risk Left Main Coronary Artery Bypass Surgery Supported by the Impella Recover LP 2.5 Assist Device: An Alternative Insertion Technique. Kucukaksu S, Ergenoglu MU, Yildiz CE, Yerebakan H, Sayin M, Degertekin M. The Heart Surgery Forum 2009;12:1076.

First Turkish experiences of assisted beating-heart coronary artery bypass graft with the Impella Microaxial Ventricular Assist Device. Yildiz CE, Sayin M, Yerebakan H, Kucukaksu S. Heart Surg Forum. 2010;13:E60-2.

Bolooki H. Clinical application of the intra-aortic balloon pump. 3rd ed. Armonk, NY:Futura publishing company, Inc, 1998.

Bolooki H. Physiology of balloon-pumping. In Bolooki, H.(ed): Clinical application of intra-aortic balloon pump. Mount Kisco, NY Futura, 1984;57-126.

Nunez L, Aguado MG, Iglesias A, Larrea JL. Transaortic cannulation for balloon pumping in a “crowded aorta”. Ann Thoracic Surg, 1980;30:400-2.

Symbas PN, McKeown PP, Santora AH. Pulmonary artery balloon counterpulsation for treatment of intraoperative right ventricular failure. Ann Thorac Surg, 1985;39:437.

McCarthy PM, Golding LAR. Temporary mechanical circulatory support. In, Cardiac Surgery in the Adult. Edited by Edmunds LH, Jr. The McGraw-Hill companies, Inc. USA, chapter, 1997;11;319-37.

Jarmolowski CR, Poirier RL. Small bowel infarction complicating intra-aortic balloon counterpulsation via the ascending aorta. J Thorac Cardiovasc Surg, 1980; 79:735-7.

Minich L, Tani L, McGough E et al. A novel approach to pediatric intraaortic balloon pump timing using Mmode echocardiography. Am J Cardiol, 1997;80:367-9.

Basket RF, Ghali WA, Maitland A et al. The intraaortic balloon in cardiac surgery. Ann Thorac Surg, 2002; 74:1276-87.

Holman W, Qing L, Kiefe C et al. Prophylactic value of preincision intra-aortic balloon pump: Analysis of a state-wide experience. J Thorac Cardiovasc Surg, 2000;120:1112-9.

37. Dyub AM, Whitlock RP, Abouzahr LL, Cinà CS. Preoperative intra-aortic balloon pump in patients undergoing coronary bypass surgery: A systematic review and meta-analysis. J Card Surg, 2008;23:79-86. Bahekar A, Singh M, Singh S et al. Cardiovascular Outcomes Using Intra-Aortic Balloon Pump in HighRisk Acute Myocardial Infarction With or Without Cardiogenic Shock: A Meta-Analysis. J Cardiovasc Pharmacol Ther, 2011 Feb 18.

Goldstein D. Invited commentary. Ann Thorac Surg, 2002;74:751-2.

Kucukaksu S, Ergenoglu MU, Yildiz CE et al. High-risk left main coronary artery bypass surgery supported by the Impella Recover LP 2.5 assist device: an alternative insertion technique. Heart Surg Forum. 2009; 12:E324-6.

Dens J, Meyns B, Hilgers RD et al. First experience with the Impella Recover(R) LP 2.5 micro axial pump in patients with cardiogenic shock or undergoing high-risk revascularisation. EuroIntervention. 2006; 2:84-90.

Yildiz CE, Sayin M, Yerebakan H, Kucukaksu S. First Turkish experiences of assisted beating-heart coronary artery bypass graft with the Impella Microaxial Ventricular Assist Device. Heart Surg Forum. 2010;13:E60-2.

Rose DM, Connolly M, Cunningham JN Jr, Spencer FC. Technique and results with a roller pump left and right heart assist device. Ann Thorac Surg, 1989; 47:124-9.

Saxton GA Jr, Andrews CB. An ideal heart pump with hydrodynamic characteristics analogous to the mammalian heart.Trans Am Soc Artif Intern Organs, 1960;6:288-0.

Golding LR, Gloves LK, Peter M et al. Initial clinical experience with a new temporary left ventricular assist device. Ann Thorac Surg, 1980;29:66-9.

Curtis JJ, Walls JT, Wagner-Mann CC et al. Centrifugal pumps: Description of devices and surgical techniques. Ann Thorac Surg, 1999;68:666-71.

Curtis JJ, Walls JT, Boley TM et al. Autopsy findings in patients on postcardiotomy centrifugal ventricular assist. ASAIO J, 1992;38:688-90.

Noon GP, Ball JW Jr, Papaconstantinou HT. Clinical experience with BioMedicus centrifugal ventricular support in 172 patients. Artif Organs, 1995;19:756-60.

Curtis JJ, Wagner-Mann C. Extracorporeal support: Centrifugal Pumps. In: Goldstein DJ, Oz MC (eds): Cardiac Assist Devices, Futura Publishing Company, Inc. Armonk NY, USA, 2000;215-233.

Mehta SM, Aufiero TX, Pea WE Jr et al. Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation. Sixth official report- 1994. J Heart Lung Transplant, 1995;14:585-93.

Magovern JA. Cardiac Assist Technology: The Tandem Heart. Presented at the fifthy International Conference on circulatory support device for severe cardiac failure, New York, 2000;15-7.

Intermediate Clinical Performance of the Levitronix CentriMag Ventricular Assist Device in Supporting Cardiogenic Shock Patients.Kenneth Liao; Sara Shumway; Monica Colvin-Adams; Emil Missov; Ranjit John. Circulation. 2010;122:A296

Ozdogan ME, İriz E, Qarandaghi L ve ark. Kalp nakline köprü olarak biventriküler dolaşım destek cihazları. 2. TÜYOD Kongresi Kitapçığı 1:S02.

Spencer FC, Eisman B, Trinke JK. Assisted circulation for cardiac failure following intracardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg, 1965;49:56-73

Kaplan RJ, Smedira NG. Extracorporeal membrane oxygenator in adults. In Goldstein DJ, Oz MC (eds): Cardiac Assist Devices, Futura Publishing Company, Inc. Armonk NY, USA. chapter, 2000;20:263-73.

Delius R, Anderson H, Schumacher R et al. Venovenous compares favorably with venoarterial access for extracorporeal membrane oxygenation in neonatal respiratory failure. J Thorac Cardiovasc Surg, 1993; 106:329-38.

Smedira NG, Wudel JH, Hlozek CC et al. Venovenous extracorporeal life support for patients after cardiotomy. ASAIO J, 1997;43:M444-6.

Gazmuri RJ, Weil MH, von Planta M et al. Cardiac resuscitation by extracorporeal circulation after failure of conventional CPR. J Lab Clin Med, 1991;118:65-73.

Willms DC, Atkins PJ, Dembitsky WP, et al. Analysis of clinical trends in a program of emergent ECLS for cardiovascular collapse. ASAIO J, 1997;43:65-8.

Phlillips SJ, Zeff RH, Kongtahworn C et al. Percutaneous cardiopulmonary bypass: Application and indication for use. Ann Thorac Surg, 1989;47:121.

Kurusz M. Zwiscjenberger JB: Percutaneous cardiopulmonary bypass for cardiac emergencies. Perfusion, 2002;17:269-77.

Smedira NG, Wudel CH, Hlozek CC et al. Extracorporeal life support as a bridge to left ventricular assist device. ASAIO J, 1997;43:33.

Meyer DM, Jessen ME, Ring WS. Results of ECMO in neonates with sepsis. JTCVS, 1995;109:419-27.

Ko WJ, Lin CY, Chen RJ et al. Extracorporeal membrane oxy igenation support for adult postcardiectomy cardiogenic shock. Ann Thorac Surg, 2002;73:538-45.

Moazami N, Smedira NG, McCarthy PM et al. Clinical experience with 229 adults on ECMO: Survival at 5 years. Presented at the fifth international conference on circulatory support devices for severe cardiac failure, New York, 2000;15-7.

Wang SS, Ko WJ, Chen YS et al. Mechanical bridge with extracorporeal membrane oxygenation and ventricular assist device to heart transplantation. Artif Organs, 2001;25:599-602.

Kihara S, Kawai A, Endo M, et al. Extracorporeal membrane oxygenation and left ventricular assist device: A case of double mechanical bridge. Heart Vessels, 2002;16:164-6.

Spiwak AJ. Transport issues with patients on ECMO. Presented at the I. Cleveland Clinic Foundation Heart failure&Circulatory support summit, Cleveland, Ohio, 2002;22-5.

Duncan BW, Hraska V, Jonas R et al. Mechanical circulatory support in children with cardiac disease. J Thorac Cardiovasc Surg, 1999;117:529-42.

Jett GK. ABIOMED BVS 5000. Experience and potential advantages. Ann Thorac Surg, 1996;61:301-4.

Guyton RA, Schonberger JPAM, Everts PA et al. Postcardiotomy shock: Clinical evaluation of the BVS 5000 biventricular support system. Ann Thorac Surg, 1993;56:346-56.

Arabia FA, Paramesh V, Toporoff B et al. Biventricular canulation for the Thoratec ventricular assist device. Ann Thorac Surg, 1998;66:2119-2120.

Couper G, Dekkers R, Adams DH. The logistic and cost-effectiveness of circulatory support. Advantages of the Abiomed BVS 5000. Ann Thorac Surg, 1999;68: 646-9.

Tsai FC, Marelli D, Laks H et al. Short-term bridge to heart transplant using the BVS 5000 external ventricular assist device. Am J Transplant, 2002;2:646-51.

Mehta SM, Christenson D, Sun B et al. Utilization of the ABIOMED BVS 5000 circulatory support system in the resuscitation of patients with acute heart failure. Presented at the fifth international conference on circulatory support devices for severe cardiac failure, New York, Sept 15-17,2000.

Morgan J, Stewart A, Lee BJ, Oz M. Role of the Abiomed BVS5000 device for short-term support and bridge to transplantation. ASAIO 2024:50(4);360-363.

T. Unoki , T. Nakayama , Y. Tsurusaki. Combined use of VA-ECMO and Impella (ECPELLA) improves shortand long-term mortality in patients with cardiogenic shock who received VA-ECMO. European Heart Journal 2023: 44 (Suppl 2);

Pierce WS, Brighton JA, O’Bannon W et al. Complete left ventricular bypass with paracorporeal pump: Design and evaluation. Ann Surg, 1974;180:418-26.

Hill JD, Farrar DJ, Hershon JJ et al. Use of prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N Engl J Med, 1986;314:626-8.

Farrar DJ. The thoratec ventricular assist device: A paracorporeal pump for treating acute and chronic heart failure. Seminars in Thorac and Cardiovasc surg 12:243-250,2000.

Hill JD, Farrar D, Naka Y et al. Positive Displacement Ventricular Assist Devices. ISHLT Monograph Series Elsevier Inc. New York. 2006;4:53-75.

Frazier OH. Long-term mechanical circulatory support. In. Cardiac surgery in the adults. edited by Edmunds LH, Jr. The McGraw-Hill companies, Inc USA, 1997;51:1477-90.

Farrar DJ, Hill JD. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg, 1993;55:276-82.

Farrar DJ; Hill JD, Pennington DG et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the Thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg, 1997;113:202-9.

Mehta SM, Boehmer JP, Pae WE Jr et al. Bridge to transplant equals extented survival for patients undergoing LVAD support when compared with long-term medical management. ASAIO J, 1996;42:406-10.

Körfer R, El-Banayosy A, Posival H et al. Mechanical circulatory support: The Bad Oeynhousen experience. Ann Thorac Surg, 1995;59:S56-63.

Farrar DJ, Körfer R, El-Banayosy A et al. First clinical use of the Thoratec TLC-II portable VAD driver in ambulatory and patient discharge settings. ASAIO J, 1998;44:35A.

Hetzer R, Hennig E, Schiessler A, et al. Mechanical support and heart transplantation. J Heart Lung Transplant, 1992;11:175-81.

Hetzer R, Loebe M, Potapov EV et al. Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children. Ann Thorac Surg, 1998; 66:1498-506.

Loebe M, Hennig E, Müller J et al. Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy and for permanent replacement. Eur J Cardiothorac Surg, 1997; 11:S11-S24.

Pasic M, Bergs S, Hennig E et al. Simplified technique for impantation of a left ventricular assist system after previous cardiac operations. Ann Thorac Surg, 1999; 67:562-4.

Loebe M, Kaufmann F, Hetzer R. The Berlin Heart. In: Cardiac Assist Devices. Goldstein DJ, Oz MC (eds). Futura publishing company, Inc. NY, 2000;275-87.

Ayik F, Oguz E, Engin C, Yagdi T, Atay Y, Ozbaran M. Surgical therapy of end-stage heart failure in pediatric patient. Transplant Proc, 2011;43:935-7.

Goldstein DJ. Intracorporeal support: Thermo Cardiosystems ventricular assist device. In: Goldstein DJ and Oz MC (eds). Cardiac Assist Devices, Armonk NY: Futura Publishing Co Inc, 2000;307-321.

Slater PJ, Rose EA, Levin HR et al. Low thromboembolic risk without anticoagulation using advanceddesign left ventricular assist devices. Ann Thorac Surg, 1996;62:1321-7.

Itescu S, Ankersmit HJ, Kocher AA et al. Immunobiology of left ventricular asist devices. Prog Cardiovasc Dis, 2000;43:67-80.

Frazier OH, Rose EA, Macmanus Q et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg, 1992;53:1080-90.

Frazier OH, Rose EA, Oz MC et al. Multicentric clinical evaluation of the Heartmate vented electric left ventricular asist system in patients awaiting heart transplantation. J Heart Lung Transplant, 2001;20:201-2.

Kasirajan V, McCarthy PM, Hoercher KJ et al. Clinical experience with long-term use of implantable left ventricular assist devices: Indications, implantation and outcomes. Semin Thorac Cardivascular Surg, 2000; 12:229-237.

Navia JL, Smedira NG, Banbury MK et al. Single center experience with implantable left ventricular assist devices. Presented at the fifthy International Conference on circulatory support device for severe cardiac failure, New York, 2000;15-17.

Portner PM, Oyer PE, Jassawalla JS et al. An alternative in endstage heart disease: Long-term ventricular assistance. Heart Transplant, 1983;III:47-59.

Portner PM, Oyer PE, McGregor CGA et al. First human use of an electrically powered implantable ventricular assist system. Artif Organs, 1985;9:36.

Dohmen PM, Laube H, de Jonge K et al. A reliable test to detect impending pump failure. Tex Heart Inst J, 2002;28:139-41.

El-Banayosy A, Deng M, Loisance DY et al. The European experience of Novacor left ventricular assist therapy as a bridge to transplant: A restrospective multicentre study. European Journal of Cardiothoracic Surg, 1999;15:835-41.

Mueller J, Wallukat G, Weng YG et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy, Circulation, 1997;96:542-9.

Mehta SM, Pae WE. The Pennsylvania State University totally implantable left ventricular assist device and total artificial heart. In: Goldstein DJ and Oz MC (eds). Cardiac Assist Devices, Armonk NY: Futura Publishing Co, Inc, 2000;403-16.

Mehta SM, Silber D, Boehmer JP, Christensen D, Pae WE Jr. Report of the first U.S. patient successfully supported long term with the LionHeart completely implantable left ventricular assist device system. ASAIO J; 2006;52:31-2.

Pae WE, Connell JM, Adelowo A et al. Clinical Utility Baseline Study (CUBS) Group. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe.. J Heart Lung Transplant. 2007;26:219-29.

Mehta SM, Pae WE, Rosenberg G et al. The LionHeart LVD-2000: A completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg, 2001;71:156-61.

El-Banayosy A, Arusoglu L, Kizner L et al. Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure.. Ann Thorac Surg. 2003;75:1469-75.

Frazier OH. Future directions of cardiac assistence. Seminars in Thorac and cardiovasc Surg, 2000;12: 251-8.

Nose Y, Yoshikawa M, Murabayashi S et al. Development of rotary blood pump technology: Past, present, and future. Artif Organs, 2000;20:412-20.

Potapov EV, Loebe M, Nasseri BA et al. Pulsatile flow in patients with a novel nonpulsatile implantable ventricular assist device. Circulation, 2000;102(Suppl III):183-7.

Butler KC, Moise JC, Wampler RK. The Hemopump-a new cardiac prosthetic device. IEEE Trans Biomed Eng, 1990;37:193.

Weiselthaler G, Schima H, Hiesmayer M et al. First clinical experience with the DeBakey VAD continuousaxial flow pump for bridge to transplantation. Circulation, 2000;101:356-59.

Noon GP, Deborah LM, Irwin S et al. Clinical experince with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg, 2001;71:133-8.

Rothenburger M, Wilhem MJ, Hammel D et al. Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation, 2002;106(Suppl 1):189-92.

Jarvik R, Frazier OH, Westaby S et al. Initiation of clinical use of the Jarvik 2000 Heart. ASAIO J, 2000;46:156.

Frazier OH, Myers TJ, Jarvik RK et al. Research and development of an implantable, axial-flow left ventricular assist device: The Jarvik 2000 Heart. Ann Thorac Surg, 2001;71:125-32.

Westaby S, Banning AP, Jarvik R et al. First permanent implant of the Jarvik 2000 Heart. The Lancet, 2000; 356:900-3.

Frazier OH. The Jarvik 2000 continuous flow left ventricular assist system. Presented at the I. Cleveland Clinic Foundation Heart failure&Circulatory support summit, Cleveland, Ohio, 2002;22-5.

Westaby S, Frazier OH, Beyersdorf F et al. The Jarvik 2000 Heart. Clinical validation of the intraventricular position. Eur J Cardiothorac Surg, 2000;22:228-32.

Kormos RL. HeartMate II and HeartMate III. An update. Presented at the I. Cleveland Clinic Foundation Heart failure&Circulatory support summit, Cleveland, Ohio, 2002;22-25.

Pagani FD, Miller LW, Russell SD. Extended mechanical circulatory support with a continuous flow rotary left ventricular assist device. Journal of the American College of Cardiology, 2009;54:312-21.

Hetzer R, Weng Y, Potapov EV et al. First experiences with a novel magnetically suspended axial flow left ventricular assist device. Eur J Cardiothorac Surg. 2004;25:964-70.

Schmid C, Tjan TD, Etz C et al. First clinical experience with the Incor Left Ventricular Assist Device. Presented at the Seventh international symposium on magnetic bearings, Zurich, 2000;23-5.

Engin C, Ayik F, Oguz E et al. Ventricular assist device as a bridge to heart transplantation in adults. Transplant Proc, 2011;43:927-30.

Strueber M, O’Driscoll G, Jansz P, Khaghani A, Levy WC, Wieselthaler GM. Multicenter evaluation of an intrapericardial left ventricular assist system. HeartWare Investigators. J Am Coll Cardiol. 2011; 22:1375-82.

FDA: Stop Using Medtronic’s Heartware Ventricular Assist Device. Bridget M. Kuehn, MS.JAMA.2021;326(3):215.doi:10.1001/jama.2021.11386.

Netuka I, Sood P, Pya Y, Zimpfer D, Krabatsch T, Garbade J, et al. Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study. J Am Coll Cardiol 2015;66:2579–89.

Mehra MR, Goldstein DJ, Cleveland JC, Cowger JA, Hall S, Salerno CT, et al. Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial. JAMA 2022;328:1233–42.

Schmitto JD, Shaw S, Garbade J, et al., ELEVATE Registry: HeartMate 3 LVAD Long-Term Outcomes. European Heart Journal, Volume 45, Issue 8, 21 February 2024, Pages 613–625,

Allen RS, Slaughter MS, Ahmed MM, et al. COMPETENCE Trial: The EVAHEART 2 continuous flow left ventricular assist device. Journal of Heart and Lung Transplantation, 2023-01-01, Volume 42, Issue 1, Pages 33-39.

Golding LA, El-Banayosy A, Kormos R et al. Emerging left ventricular asist devices.Mechanical Circulatory Support (eds) Frazier OH, Kirklin JK: ISHLT Monograph Series, 2006;1:205-17.

Chen JM, DeRose JJ, Slater JP et al. Improved survival rates support left ventricular assist device implantation early after myocardial infarction. J Am Coll Cardiol, 1999;33:1903-8.

Williams MR and Oz MC. Indications and patient selection for mechanical ventricular asistance. Ann Thorac Surg, 2001;71:86-91.

Chen JM, Spanier TB, Gonzalez JJ et al. Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance. J Heart Lung Transplant, 1999;18:351-7.

Fasseas P, Kukalek SP, Samuels FL et al. Ventricular assist device support for management of sustained ventricular arrhythmias. Tex Heart Inst J, 2002;29:33-6.

Albes JM, Eckstein FS, Heinemann MK et al. Successful weaning of a transplanted heart from biventricular assist device. Ann Thorac Surg, 2000;70:277-8.

Gambino A, Testolin L, Gerosa G et al. New trends in heart transplantation. Transplantation proceedings, 2001;33:353-356.

Gronda E, Mangiavacchi M, Frigerio M et al. Determination of candidacy for mechanical circulatory support: Importance of clinical indices. J Heart Lung Transplant, 2000;19;83-8.

Rose EA, Gelijns AC, Moskowitz AJ et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med, 2001;345:1435-43.

Long JW. Rematch trial LVAD performance, adverse events and targets to improve outcomes. Utah Artificial Heart Program. Presented at the I.Cleveland Clinic Foundation Heart Failure&Circulatory support Summit, Cleveland, Ohio, 2002;22-5.

Pennington DG, Oaks T, Lohmann DP. Permanent ventricular assist device support versus cardiac transplantation. Ann Thorac Surg, 1999;68:729-33.

Deng MC, Weyand M, Hammel D et al. Selection and management of ventricular assist device patients: The Muenster experience. J Heart Lung Transplant, 2000; 19:77-82.

Piccione W Jr. Bridge to transplantation with the HeartMate device. J Card Surg, 2001;16:272-9.

Lynne Warner-Stevenson. The evolving role of mechanical circulatory support in advenced heart failure. Mechanical Circulatory Support (eds) Frazier OH, Kirklin JK: ISHLT Monograph Series 1 2006:181-203.

Sun BC. Device selection. In: Goldstein DJ and Oz MC (eds). Cardiac Assist Devices, Armonk NY: Futura Publishing Co, Inc, 2000;387402.

Fukamachi K, McCarthy PM, Smedira NG, et al. Preoperative risk factors for right ventricular failure after implantable left ventricular asisst device insertion. Ann Thorac Surg, 1999;68:2181-4.

Swartz M, Votapka JV, McBride LR, et al. Risk stratification in patients bridged to cardiac transplantation. Ann Thorac Surg, 1994;58:1142-5.

Miller LW. Patient selection for permanent LVAD therapy. Presented at the I.Cleveland Clinic Foundation Heart Failure&Circulatory support Summit, Cleveland, Ohio, 2002;22-5.

Gracin N, Johnson MR, Spokas D et al. The use of APACHE II scores to select candidates for left ventricular assist device placement. J Heart Lung Transplant, 1998;17:1017-23.

Lietz K, Long JW, Kfoury AG et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: Implications for patient selection. Circulation. 2007;116:497-505.

Tittle SL, Mandapati D, Kopf GS et al. Alternative technique for implantation of left ventricular assist systems: Left thoracotomy for reoperative cases. Ann Thorac Surg, 2002;73:994-6.

McCarthy PM, Savage RM, Fraser CD et al. Hemodynamic and physiologic changes during support with an implantable LVAD. J Thorac Cardiovasc Surg, 1995;109:409-18.

Nakatani S, Thomas JD, Vandervoort PM et al. Left ventricular diastolic filling with an implantable ventricular assist device: Beat to beat variability with overall improvement. J Am Coll Cardiol, 1997;30:1288-94.

Santamore WP, Gray LA Jr. Left ventricular contributions to right ventricular systolic function LVAD support. Ann Thorac Surg, 1996;61:351-6.

Chow E, Farrar DJ. Right heart function during prosthetic left ventricular assistance in a porcine model of congestive heart failure. J Thorac Cardiovasc Surg, 1992;2:569-78.

Farrar DJ. Ventricular interactions during mechanical circulatory support. Semin Thorac Cardiovasc Surg, 1994;6:163-8.

Pae WE Jr, Miller CA, Matthews Y et al. Ventricular assist devices for post cardiotomy cardiogenic shock: A combined registry experience. J Thorac Cardiovasc Surg, 1992;104:541-53.

Holman WL, Bourge RC, Kirklin JK. Case report: Circulatory support for seventy days with resolution of acute heart failure. J Thorac Cardiovasc Surg, 1991;102:932-3.

Hetzer R, Muller J, Weng Y et al. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg, 1999;68:742-9.

Westaby S, Katsumata T, Pigott D et al. Mechanical bridge to recovery in fulminant myocarditis. Ann Thorac Surg, 2000;70:278-83.

Moravec CS, Cell on support. Presented at the I. Cleveland Clinic Foundation Heart Failure&Circulatory support Summit, Cleveland, Ohio, 2002;22-5.

Küçükaksu DS. Ventriküler destek sistemleri. Kalp ve Damar Cerrahisi. M. Paç, A Akçevin, SA. Aka, S. Buket, T. Sarıoğlu (eds). MN Medikal&Nobel, Ankara, 2004;351-416.

Vatta M, et al. Molecular remodelling of dystrophin in patients with end-stage cardiomyophaties and reversal in patients on assistance device therapy. Lancet 2002;359:936-41.

McNamara DM et al. Controlled trial of intravenous immune glogulin in recent-onset dilated cardiomyophaty. Circulation, 2001:103:2254-9.

Frazier OH, Myers TJ. Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg, 1999;68:734-41.

Goldstein DJ, Seldomridge JA, Chen JM et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg, 1995;59:1063-8.

Oz M, Argenziano M, Catanese K et al. Bridge experience with long-term implantable left ventricular assist device. Are they an alternative to transplantation? Circulation, 1997;7:1844-52.

Chen JM, Rose EA. Management of perioperative right-sided circulatory failure. In: Goldstein DJ and Oz MC (eds). Cardiac Assist Devices, Armonk NY: Futura Publishing Co Inc, 2000;83-101.

Chen JM, Levin HR, Rose EA et al. Experience with right ventricular assist devices for perioperative rightsided circulatory failure. Ann Thorac Surg, 1996;61: 305-10.

Kormos RL, Gasior TA, Kawai A et al. Transplant cardidate’s clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg, 1996; 111:773-83.

Smedira NG, Massad MG, Navia J et al. Pulmonary hypertension is not a factor for RVAD use and death after left ventricular assist system support. ASAIO J, 1996;42:733-5.

Piccione Jr. M. Left ventricular assist device implantation. Short and long-term surgical complications. J Heart Lung Transplant, 2000;19:89-94.

Prendergast TW, Todd BA, Beyer III AJ et al. Management of left ventricular assist device infection with heart transplantation. Ann Thorac Surg, 1997;64:142-7.

Ankersmit HJ, Itescu S. Immunobiology of left ventricular assist device. In: Goldstein DJ and Oz MC (eds). Cardiac Assist Devices, Armonk NY: Futura Publishing Co, Inc, 2000;193-211.

Holman WA, Teitel ER, Itescu S. Biologic barriers to mechanical circulatory support. Mechanical Circulatory Support (eds) Frazier OH, Kirklin JK: ISHLT Monograph Series 1 2006:9-32

Bonaros N, Mueller M, Salat A, et al. Extensive coagulation monitoringin patients after implantation of the MicroMed DeBakey continuous flow axial pump. ASAIO J, 2004;50:424-31.

Mandak J, Aaronson K, Mancini D. Serial assessment of exercise capacity post cardiac transplant. J Heart Lung Transplant, 1995;14:468-78.

Frazier OH, Rose EA, McCarthy P et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Thorac Surg, 1995;222:327-38.

Dew MA, Kormos RL, Winowich S et al. Human factors in ventricular assist device recipients and their family caregivers. Presented at the American Society for Artificial Internal Organs. San Diego: 1999.

Hutchinson J, Scott DA, Clegg AJ et al. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure. Expert Rev Cardiovasc Ther, 2008;6:175-85.

Mahle WT, Ianucci G, Vincent RN, Kanter KR. Costs associated with ventricular assist device use in children. Ann Thorac Surg, 2008;86:1592-7.

Karl TR, Horton SB. Centrfugal pump ventricular asist device in pediatric cardiac surgery. In: Duncan BW, editor. Mechanical support for cardiac and respiratory failure in pediatric patients. New York: Marcel Dekker; 2001:p;21-47.

Blume ED, Naftel DC, Bastardi HJ et al. Outcome of children listed for transplant and bridged with ventricular assist devices. A Multi-institutional study. J Heart Lung Transplant, 2005;24:S75.

Alexi-Meskishvili V, Hetzer R, Weng Y et al. The use of Berlin Heart in Children. In: Duncan BW, editor. Mechanical support for cardiac and respiratory failure in pediatric patients. New York: Marcel Dekker; 2001;p:287-314.

Imamura M, Hale S, Johnson CE et al. The first successful DeBakey VAD child implantation as a bridge to transplant. ASAIO J. 2005;51:670-2.

Seigenthaler MP, Westaby S, Frazier OH et al. Advanced heart failure: Feasibility study of long-term continuous axial flow pump support. Eur Heart J 2005;26: 1031-8.

Pamboukian SV, Tallaj JA, Brown RN et al. Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol. J Heart Lung Transplant. 2011; Apr 20.

Sheikh FH, Russell SD. HeartMate II continuous-flow left ventricular assist system. Expert Rev Med Devices. 2011;8:11-21.

Left ventricular device as destination therapy: are we there yet? Badiwala MV, Rao V. Curr Opin Cardiol. 2009;24:184-9.

Van Meter CH, Ordoyne SKH, Kateiva JE. Ventricular assist device programs: Design and function. Ann Thorac Surg, 1999;68:643-5.

Slaughter MS, Silver MA, Farrar DJ, et al. A new method of monitoring recovery and weaning the Thoratec left ventricular assist device. Ann Thorac Surg, 2001;71:215-218.

Dew MA, Kormos RL, Roth LH et al. Life quality in the era of bridging to cardiac transplantation. Bridge patients in an outpatient setting. ASAIO J 1993;39:145-52.

Starling RC, Naka Y, Boyle AJ et al. Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation A Prospective Study Using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2011;10:1890-8.

Deng MC, Edwards LB, Hertz MI et al. Mechanical circulatory support device database of the international society for heart and lung transplantation: Third annual report 2005. Journal of Heart and Lung Transplantation, 2005;24:1182-7.

Alba AC, McDonald M, Rao V, Ross HJ, Delgado DH. The effect of ventricular assist devices on long-term post-transplant outcomes: A systematic review of observational studies. Eur J Heart Fail, 2011:6.

Franco KL. New devices for chronic ventricular support. J Card Surg, 2001;16:178-92.

Evans RW. Costs and insurance coverage associated with permanent mechanical cardiac assist/replacemant devices in the Unites States. J Card Surg, 2001;16:280-93.

Frazier OH. Mechanical circulatory support: New advances, new pumps, new ideas. Semin Thorac Cardiovasc Surg, 2002;14:178-86.

Finocchiaro T, Heinke S, Behbahani M et al. Methods of design, simulation, and control for the development of new VAD/TAH concepts. Biomed Tech, 2009;54:269- 81.

Meyns BP, Simon A, Klotz S et al. Clinical benefits of partial circulatory support in New York heart association class IIIB and early class IV patients. Eur J Cardiothorac Surg. 2011;39:693-8.

Williams ML, Trivedi JR, McCants KC et al. Heart transplant vs left ventricular assist device in heart transplant-eligible patients. Ann Thorac Surg, 2011; 91:1330-4.